{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:55:41Z","timestamp":1790070941396,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1378\/chest.126.2.540","type":"journal-article","created":{"date-parts":[[2004,8,9]],"date-time":"2004-08-09T21:58:38Z","timestamp":1092088718000},"page":"540-546","source":"Crossref","is-referenced-by-count":108,"title":["C-Reactive Protein and Body Mass Index Predict Outcome in End-Stage Respiratory Failure"],"prefix":"10.1016","volume":"126","author":[{"given":"No\u00ebl J.M.","family":"Cano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Pichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Court-Fortun\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Cynober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"G\u00e9rard-Boncompain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Cuvelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Laaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Melchior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Rapha\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe M.","family":"Pison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.126.2.540_bib1","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","article-title":"Alternative projections of mortality and disability by cause","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1378\/chest.126.2.540_bib2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1378\/chest.109.3.741","article-title":"Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation","volume":"109","author":"Chailleux","year":"1996","journal-title":"Chest"},{"key":"10.1378\/chest.126.2.540_bib3","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1164\/ajrccm.157.6.9705017","article-title":"Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease","volume":"157","author":"Schols","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.2.540_bib4","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1164\/ajrccm\/139.6.1435","article-title":"Body weight in chronic obstructive pulmonary disease: the National Institutes of Health intermittent positive-pressure breathing trial","volume":"139","author":"Wilson","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.126.2.540_bib5","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1164\/ajrccm\/140.6.1544","article-title":"Effects of nutritional status on exercise performance in patients with chronic obstructive disease","volume":"140","author":"Gray-Donald","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.126.2.540_bib6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1164\/ajrccm\/147.5.1151","article-title":"Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation","volume":"147","author":"Schols","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.126.2.540_bib7","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1164\/ajrccm.153.3.8630580","article-title":"Nutritional status and mortality in chronic obstructive pulmonary disease","volume":"153","author":"Gray-Donald","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.2.540_bib8","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1164\/ajrccm.160.6.9902115","article-title":"Prognostic value of nutritional status in chronic obstructive pulmonary disease","volume":"160","author":"Landbo","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.2.540_bib9","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1378\/chest.123.5.1460","article-title":"Prognostic value of nutritional depletion in patients with long-term oxygen therapy: data from the ANTADIR observatory","volume":"123","author":"Chailleux","year":"2003","journal-title":"Chest"},{"key":"10.1378\/chest.126.2.540_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1183\/09031936.02.01812001","article-title":"Nutritional depletion in patients on long-term oxygen therapy and\/or home mechanical ventilation","volume":"20","author":"Cano","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.126.2.540_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1054\/clnu.2001.0498","article-title":"Should a single centre for the assay of biochemical markers of nutritional status be mandatory in multicentric trials?","volume":"20","author":"Cardenas","year":"2001","journal-title":"Clin Nutr"},{"key":"10.1378\/chest.126.2.540_bib12","first-page":"7","article-title":"Standardized lung function testing","volume":"19","author":"Quanjer","year":"1983","journal-title":"Bull Eur Physiopathol Respir"},{"key":"10.1378\/chest.126.2.540_bib13","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/thx.39.11.818","article-title":"Effect of encouragement on walking test performance","volume":"39","author":"Guyatt","year":"1984","journal-title":"Thorax"},{"key":"10.1378\/chest.126.2.540_bib14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/00031305.1990.10475751","article-title":"A suggestion for using powerful and informative tests of normality","volume":"44","author":"D'Agostino","year":"1990","journal-title":"Am Stat"},{"key":"10.1378\/chest.126.2.540_bib15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1164\/ajrccm.154.4.8887592","article-title":"Outcomes following acute exacerbation of severe chronic obstructive lung disease: the SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) [erratum published in Am J Respir Crit Care Med 197: 155:386]","volume":"154","author":"Connors","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.2.540_bib16","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1378\/chest.121.5.1449","article-title":"Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD","volume":"121","author":"Miravitlles","year":"2002","journal-title":"Chest"},{"key":"10.1378\/chest.126.2.540_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1183\/09031936.97.10020417","article-title":"Muscle weakness is related to utilization of health care resources in COPD patients","volume":"10","author":"Decramer","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.126.2.540_bib18","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1164\/ajrccm.164.6.2006012","article-title":"Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation: EFRAM study","volume":"164","author":"Garcia-Aymerich","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.2.540_bib19","first-page":"681","article-title":"Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema","volume":"i","author":"Medical Research Council Party","year":"1981","journal-title":"Lancet"},{"key":"10.1378\/chest.126.2.540_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7326\/0003-4819-93-3-391","article-title":"Continuous or nocturnal oxygen therapy in hypoxemic obstructive lung disease: a clinical trial","volume":"93","author":"Nocturnal Oxygen Therapy Trial Group","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.2.540_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1183\/09031936.01.17303370","article-title":"Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids","volume":"17","author":"Schols","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.126.2.540_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0954-6111(98)90032-4","article-title":"Oral corticosteroid treatment during long-term oxygen therapy in chronic obstructive pulmonary disease: a risk factor for hospitalization and mortality in women","volume":"92","author":"Strom","year":"1998","journal-title":"Respir Med"},{"key":"10.1378\/chest.126.2.540_bib23","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1378\/chest.117.3.662","article-title":"Acute exacerbation of COPD: factors associated with poor treatment outcome","volume":"117","author":"Dewan","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.126.2.540_bib24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1378\/chest.124.2.459","article-title":"Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD","volume":"124","author":"Groenewegen","year":"2003","journal-title":"Chest"},{"key":"10.1378\/chest.126.2.540_bib25","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1378\/chest.111.3.732","article-title":"Adverse effects of corticosteroid therapy for COPD: a critical review","volume":"111","author":"McEvoy","year":"1997","journal-title":"Chest"},{"key":"10.1378\/chest.126.2.540_bib26","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm\/146.3.800","article-title":"Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma","volume":"146","author":"Decramer","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.126.2.540_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1164\/ajrccm.150.1.8025735","article-title":"Corticosteroids contribute to muscle weakness in chronic airflow obstruction","volume":"150","author":"Decramer","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.2.540_bib28","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1164\/ajrccm.153.3.8630582","article-title":"Peripheral muscle weakness contributes to exercise limitation in COPD","volume":"153","author":"Gosselink","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.2.540_bib29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1164\/ajrccm.158.2.9711023","article-title":"Peripheral muscle weakness in patients with chronic obstructive pulmonary disease","volume":"158","author":"Bernard","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.2.540_bib30","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1164\/rccm.2107031","article-title":"Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease","volume":"166","author":"Marquis","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.126.2.540_bib31","first-page":"S108","article-title":"Inflammation and atherosclerosis: the value of the high-sensitivity C- reactive protein assay as a risk marker","volume":"116","author":"Jialal","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"suppl 80","key":"10.1378\/chest.126.2.540_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1523-1755.61.s80.18.x","article-title":"Inflammation and cardiovascular risk in dialysis patients","volume":"61","author":"Wanner","year":"2002","journal-title":"Kidney Int"},{"key":"10.1378\/chest.126.2.540_bib33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-136-7-200204020-00010","article-title":"Is C-reactive protein specific for vascular disease in women","volume":"136","author":"Rifai","year":"2002","journal-title":"Ann Intern Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215311685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215311685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T04:57:38Z","timestamp":1734497858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215311685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0012369215311685"],"URL":"https:\/\/doi.org\/10.1378\/chest.126.2.540","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}